SCHEMBL6574004

SCHEMBL6574004

C[C@@H](NC(=O)c1cccnc1)C(N)=O

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 2/20 0.56
HDAC1 Q13547 2/20 0.56
HDAC6 Q9UBN7 1/20 0.56
F7 P08709 1/20 0.54
F3 P13726 1/20 0.54
SARM1 Q6SZW1 1/20 0.54
SIRT2 Q8IXJ6 1/20 0.54
SIRT6 Q8N6T7 1/20 0.54
SIRT1 Q96EB6 1/20 0.54
SIRT3 Q9NTG7 1/20 0.54
SIRT5 Q9NXA8 1/20 0.54
SIRT4 Q9Y6E7 1/20 0.54
NPC1 O15118 3/20 0.54
RAB9A P51151 3/20 0.54
TP53 P04637 2/20 0.54
SMN1; SMN2 Q16637 2/20 0.54
PREP P48147 1/20 0.52
FAP Q12884 1/20 0.52
THRB P10828 1/20 0.51
HIF1A Q16665 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8804879 1.00 LMNA (0.56) LMNAHDAC1HDAC6F7F3
SCHEMBL29589266 0.86 ALDH1A1 (0.57) LMNAHDAC1HDAC6NPC1RAB9A
SCHEMBL290434 0.86 ALDH1A1 (0.57) LMNAHDAC1HDAC6NPC1RAB9A
SCHEMBL513251 0.86 LMNA (0.60) LMNAHDAC1HDAC6NPC1RAB9A
SCHEMBL6860757 0.86 HDAC1 (0.57) LMNAHDAC1HDAC6NPC1RAB9A
SCHEMBL2797592 0.86 LMNA (0.60) LMNAHDAC1HDAC6NPC1RAB9A
SCHEMBL30151637 0.86 LMNA (0.60) LMNAHDAC1HDAC6NPC1RAB9A
SCHEMBL2794824 0.86 LMNA (0.60) LMNAHDAC1HDAC6NPC1RAB9A
SCHEMBL29748479 0.86 LMNA (0.60) LMNAHDAC1HDAC6NPC1RAB9A
SCHEMBL29588077 0.85 PREP (0.54) LMNAHDAC1HDAC6F7F3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1395551-A2 HYDROXY ALKYL AMINE DERIVATIVES AS BETA-SECRETASE INHIBITORS AND THEIR USE FOR THE TREATMENT OF ALZHEIMER'S DISEASE AND SIMILAR DISEASES Elan Pharmaceuticals, Inc. (US) 2004-03-10 EP claimed
WO-2002098849-A2 HYDROXY ALKYL AMINE DERIVATIVES AS BETA-SECRETASE INHIBITORS AND THEIR USE FOR THE TREATMENT OF ALZHEIMER’S DISEASE AND SIMILAR DISEASES ELAN PHARMACEUTICALS, INC. (US) 2002-12-12 WO claimed
EP-1395551-A2 HYDROXY ALKYL AMINE DERIVATIVES AS BETA-SECRETASE INHIBITORS AND THEIR USE FOR THE TREATMENT OF ALZHEIMER'S DISEASE AND SIMILAR DISEASES Elan Pharmaceuticals, Inc. (US) 2004-03-10 EP disclosed
WO-2002098849-A2 HYDROXY ALKYL AMINE DERIVATIVES AS BETA-SECRETASE INHIBITORS AND THEIR USE FOR THE TREATMENT OF ALZHEIMER’S DISEASE AND SIMILAR DISEASES ELAN PHARMACEUTICALS, INC. (US) 2002-12-12 WO disclosed